Walleye Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Sell |
332
-3,071
| -90% | -$1.37M | ﹤0.01% | 1463 |
|
|
2025
Q1 | $1.65M | Buy |
3,403
+3,225
| +1,812% | +$1.56M | 0.01% | 657 |
|
|
2024
Q4 | $71.7K | Sell |
178
-5,203
| -97% | -$2.1M | ﹤0.01% | 1739 |
|
|
2024
Q3 | $2.5M | Buy |
5,381
+2,596
| +93% | +$1.21M | 0.01% | 663 |
|
|
2024
Q2 | $1.31M | Sell |
2,785
-54
| -2% | -$25.3K | ﹤0.01% | 1000 |
|
|
2024
Q1 | $1.19M | Sell |
2,839
-9,416
| -77% | -$3.94M | ﹤0.01% | 971 |
|
|
2023
Q4 | $4.99M | Sell |
12,255
-14,090
| -53% | -$5.73M | 0.01% | 361 |
|
|
2023
Q3 | $9.16M | Buy |
+26,345
| New | +$9.16M | 0.02% | 233 |
|
|
2023
Q2 | – | Sell |
-9,328
| Closed | -$2.94M | – | 2889 |
|
|
2023
Q1 | $2.94M | Sell |
9,328
-46,509
| -83% | -$14.7M | 0.04% | 410 |
|
|
2022
Q4 | $16.1M | Sell |
55,837
-11,186
| -17% | -$3.23M | 0.29% | 58 |
|
|
2022
Q3 | $19.4M | Buy |
67,023
+37,649
| +128% | +$10.9M | 0.37% | 30 |
|
|
2022
Q2 | $8.28M | Buy |
29,374
+16,634
| +131% | +$4.69M | 0.23% | 88 |
|
|
2022
Q1 | $3.33M | Sell |
12,740
-18,463
| -59% | -$4.82M | 0.09% | 225 |
|
|
2021
Q4 | $6.85M | Buy |
31,203
+2,373
| +8% | +$521K | 0.21% | 93 |
|
|
2021
Q3 | $5.23K | Sell |
28,830
-2,601
| -8% | -$472 | 0.15% | 77 |
|
|
2021
Q2 | $6.34K | Buy |
31,431
+29,963
| +2,041% | +$6.04K | 0.22% | 51 |
|
|
2021
Q1 | $315 | Buy |
+1,468
| New | +$315 | 0.02% | 723 |
|
|
2020
Q4 | – | Sell |
-3,428
| Closed | -$933K | – | 1115 |
|
|
2020
Q3 | $933K | Buy |
+3,428
| New | +$933K | 0.1% | 243 |
|
|
2020
Q2 | – | Sell |
-3,818
| Closed | -$908K | – | 795 |
|
|
2020
Q1 | $908K | Buy |
3,818
+1,598
| +72% | +$380K | 0.2% | 106 |
|
|
2019
Q4 | $486K | Buy |
2,220
+1,750
| +372% | +$383K | 0.03% | 183 |
|
|
2019
Q3 | $80K | Buy |
470
+190
| +68% | +$32.3K | ﹤0.01% | 309 |
|
|
2019
Q2 | $51K | Sell |
280
-110
| -28% | -$20K | 0.01% | 318 |
|
|
2019
Q1 | $72K | Buy |
+390
| New | +$72K | 0.01% | 189 |
|